Neumora Therapeutics
Price & Volume
Stats
See more52W Range | $0.61-$17.18 |
Market Cap | $309.3M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.57 |
News
See moreYahoo Finance • 9 days ago
Apple initiated, Hershey upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Neumora outlines six upcoming clinical catalysts and prioritizes obesity program with NMRA-215
Yahoo Finance • 2 months ago
Neumora Therapeutics to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
Yahoo Finance • 2 months ago
Neumora Therapeutics soars 68% following InvestingPro's June Fair Value signal
About
CFO | Mr. Michael Lee Milligan |
Address | 490 Arsenal Way, Watertown, MA, United States, 02472 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 96 |
